Home » Kainos, Towa Conclude Sales Agreement on Influenza Virus Detection Reagent
Kainos, Towa Conclude Sales Agreement on Influenza Virus Detection Reagent
Kainos Laboratories announced on June 7 that it has signed a sales agreement with Towa Pharmaceutical, one of the leading Japanese generic drug manufacturers, on Statmark Influenza A/B, Kainos' proprietary influenza virus detection kit co-developed with Nichirei. Under the terms of the agreement, Kainos and Towa will collaborate in sales targeting general practitioners nationwide.
()a href="http://www.japancorp.net/Article.Asp?Art_ID=10267" target="_blank">Japan Corporate News Network
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May